NCT00375505View on ClinicalTrials.gov

The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Breast Cancer
Interventions
DRUG

Zoledronic acid

DRUG

Placebo

Placebo

Trial Locations (1)

35043

Novartis Investigative Site, Marburg

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY